The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration

CONCLUSION: Our study shows that a TDT equal to or less than 1 week is associated with adverse clinical factors, worse outcomes, and response in DLBCL, even after adjusting for multiple known poor prognostic factors. This was the first time that response to first-line therapy was correlated to time to treatment. Our findings support ongoing efforts to improve currently standardized prognostic tools and the incorporation of TDT into clinical trials to avoid selection bias.PMID:38151390 | DOI:10.1016/j.clml.2023.11.003

Source: Clinical Lymphoma and Myeloma - December 27, 2023 Category: Cancer & Oncology Authors: Gabriel Roman Souza Zohra Nooruddin Sophia Lee Lauren Boyle Kana Tai Lucero Snegha Ananth Kathleen Franklin Michael Mader Esteban Toro Velez Amna Naqvi Supreet Kaur Source Type: research